{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Breast Cancer Risk Assessment: Evaluation of Screening Tools for Genetics Referral
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To present the details of a descriptive study conducted to compare five breast cancer risk-screening tools to help primary care providers determine which unaffected patients to refer to genetic specialists.Learning Objectives
After completing this continuing education activity you will be able to:
- Analyze the information presented about the current status of breast cancer and its screening in the United States.
- Explain the methodology for the researchers' comparison of breast cancer risk-screening tools.
- Apply the results and clinical implications of the researchers' comparison of breast cancer risk-screening tools to your practice.
Disclosures
The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$12.95
Credits:
- AANP 1.3 CH / 0.5 APH
- DC - BON 1.3 CH
- KY-BON 1.0 CH
- GA - BON 1.3 CH
This Activity is approved for 1.3 contact hour (s) of continuing education (which includes 0.5 hour(s) pharmacology) by the American Association of Nurse Practitioners. Activity ID# 19083840.
This Activity was planned in accordance with AANP Accreditation Standards and Policies.
Awarded Advanced Pharmacology Hours
Awarded Advanced Pharmacology Hours
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: JAANP1019
Published: Oct 2019
Expires: 12/31/2026
Required Passing Score: 18/18 (100%)